Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Hemostemix Inc V.HEM

Alternate Symbol(s):  HMTXF

Hemostemix Inc. is a Canada-based clinical-stage biotechnology company. The Company’s principal business is to develop, manufacture and commercialize blood-derived stem cell therapies to treat various diseases. It is an autologous stem cell therapeutics company that holds 91 patents on the derivation of three stem cell lineages from the patient’s blood, including angiogenic cell precursors (ACP-01), neuronal cell precursors, and cardiomyocyte cell precursors. ACP-01 is a lead clinical-stage candidate, like NCP-01 and CCP-01, is generated from the patient’s blood. The Company is engaged in providing treatment for ischemia, such as ischemic cardiomyopathy, angina, peripheral arterial disease including critical limb ischemia. The Company’s proprietary technology is a personalized regenerative therapy that is administered to a patient within seven days of the initial blood draw. Its subsidiaries include Kwalata Trading Limited, Hemostemix Ltd., and PreCerv Inc.


TSXV:HEM - Post by User

Comment by milstogoon Aug 02, 2021 6:30pm
273 Views
Post# 33640590

RE:.215

RE:.215Haven't you figured it out walterthedog... most of us don't care what you have to say.  Next time do your DD before you invest in a stock. 

A little history on Walterthedog ...he goes by DocHoliday on the ceo board. He's a whinning pain in the you know where. When he can't get a response from the ceo board he comes here to dump and bash hem. He borrowed money and jumped in at .80. Admitted he didn't do any DD and expected to make a bundle and then got mad when it dropped. On the ceo board they kept telling him to cut his loses and bail but no he just wanted to whine and bash Thomas and the company.
So suck it up Walterthedog and go get yourself a life besides coming to this board and dumping on hem. Sometimes I wonder if your 
with Jeb Wood and Kyle Makofka's people the way you keep soft bashing hem. 
Most of us have been here for a long long time and we wait and will wait.
High Risk-High Reward. Or not. 
GLTA!
<< Previous
Bullboard Posts
Next >>

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse